Balchem Corporation (BCPC)

NASDAQ: BCPC · Real-Time Price · USD

160.86

-0.58 (-0.36%)

At close: Jul 14, 2026, 4:00 PM EDT

159.50

-1.36 (-0.85%)

Pre-market: Jul 15, 2026, 4:47 AM EDT

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Human Nutrition and Health Revenue	672.56M	659.39M	600.26M
Human Nutrition and Health Revenue Growth	2.00%	9.85%	8.99%
Animal Nutrition and Health Revenue	235.76M	230.85M	214.71M
Animal Nutrition and Health Revenue Growth	2.13%	7.52%	-9.91%
Specialty Products Revenue	142.43M	140.98M	132.75M
Specialty Products Revenue Growth	1.03%	6.20%	5.39%
Other and Unallocated Business Segment Revenue	6.60M	5.95M	5.97M
Other and Unallocated Business Segment Revenue Growth	11.02%	-0.35%	-19.33%
Revenue (Other)	-1.00K	-1.00K	-
Revenue (Total)	1.06B	1.04B	953.68M
Revenue (Total) Growth	1.95%	8.75%	3.39%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	771.11M	759.45M	723.30M
United States Revenue Growth	1.54%	5.00%	4.89%
Foreign Countries Revenue	286.24M	277.71M	230.38M
Foreign Countries Revenue Growth	3.07%	20.54%	-1.05%
Revenue (Other)	-1.00K	-1.00K	-
Revenue (Total)	1.06B	1.04B	953.68M
Revenue (Total) Growth	1.95%	8.75%	3.39%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Product Sales Revenue	1.06B	1.04B	951.95M
Product Sales Revenue Growth	1.95%	8.75%	3.48%
Royalty Revenue	1.92M	1.89M	1.74M
Royalty Revenue Growth	1.85%	8.75%	-30.19%
Revenue (Total)	1.06B	1.04B	953.68M
Revenue (Total) Growth	1.95%	8.75%	3.39%

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Human Nutrition and Health Earnings From Operations	155.95M	153.91M	135.96M
Human Nutrition and Health Earnings From Operations Growth	1.33%	13.20%	32.75%
Animal Nutrition and Health Earnings From Operations	19.14M	18.69M	14.01M
Animal Nutrition and Health Earnings From Operations Growth	2.44%	33.36%	-49.18%
Specialty Products Earnings From Operations	45.25M	42.90M	39.91M
Specialty Products Earnings From Operations Growth	5.48%	7.51%	15.40%
Other and Unallocated Business Segment Earnings From Operations	-6.41M	-6.17M	-6.97M
Operating Income (Total)	213.94M	209.33M	182.91M
Operating Income (Total) Growth	2.20%	14.44%	14.90%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Human Nutrition and Health Backlog	39.59B	39.96B
Human Nutrition and Health Backlog Growth	-0.93%	23.26%
Animal Nutrition and Health Backlog	11.49B	9.04B
Animal Nutrition and Health Backlog Growth	27.16%	18.27%
Specialty Products Backlog	1.93B	1.28B
Specialty Products Backlog Growth	50.54%	-52.05%
Other Business Segment Backlog	356.00M	137.00M
Other Business Segment Backlog Growth	159.85%	-38.29%
Total Backlog	53.37B	50.42B
Total Backlog Growth	5.85%	17.36%